Background and Biological Significance of GANAB

GANAB encodes the alpha catalytic subunit of glucosidase II (GII), an endoplasmic reticulum (ER)-resident heterodimeric enzyme. Glucosidase II works sequentially with glucosidase I to trim the two innermost glucose residues from the Glc₃Man₉GlcNAc₂ N-glycan precursor added co-translationally to nascent glycoproteins. This trimming step is essential for the calnexin/calreticulin cycle, the primary ER quality-control pathway that ensures correct folding of newly synthesized glycoproteins before they proceed to the Golgi apparatus.

Loss-of-function variants in GANAB have been associated with autosomal dominant polycystic kidney disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD), highlighting its clinical relevance beyond basic cell biology. The GANAB alpha subunit (encoded by the GANAB gene, also known as GII alpha) requires association with the beta subunit (PRKCSH) for full catalytic activity and correct ER localization. Recombinant Human GANAB Protein provides researchers with a defined, consistent source of this subunit to study enzyme kinetics, protein–protein interactions, and disease-related mutations in a controlled in vitro setting.

Reconstitution and Storage Guidelines

Proper handling of Recombinant Human GANAB Protein is critical to preserving enzymatic activity and experimental reproducibility. Follow the steps below as a general framework, and always consult the Certificate of Analysis (CoA) and product datasheet supplied with each lot for lot-specific conditions.

1. Centrifuge before opening: Briefly centrifuge the vial (e.g., 5–10 seconds at low speed) to consolidate lyophilized powder or any liquid at the bottom of the vial before opening.
2. Reconstitution buffer: Reconstitute lyophilized protein in sterile, ultrapure water or an appropriate buffer as specified on the datasheet (commonly PBS, pH 7.4, with a carrier protein such as 0.1% BSA to enhance stability). Use the volume indicated to achieve the recommended stock concentration.
3. Gentle mixing: Mix gently by pipetting or slow rotation. Avoid vortexing, which can cause protein denaturation and aggregation.
4. Aliquoting: Divide the reconstituted stock into single-use aliquots immediately after reconstitution to avoid repeated freeze-thaw cycles, which are a primary cause of activity loss.
5. Short-term storage: Store aliquots at 4 °C for up to 1 week if used frequently.
6. Long-term storage: Store aliquots at -80 °C. Adding a cryoprotectant (e.g., glycerol to 10–20% final concentration) may further stabilize the protein during freeze-thaw; confirm compatibility with downstream assays.

Note: Specific buffer compositions, recommended concentrations, and shelf-life data are provided on the product datasheet for SKU rp366605. Always defer to the datasheet for authoritative values.

Recommended Applications and Experimental Considerations

Recombinant Human GANAB Protein is suitable for a range of in vitro research applications. Representative uses include:

• Enzyme activity assays: Measurement of glucosidase II alpha subunit activity using synthetic fluorogenic or chromogenic glucoside substrates (e.g., 4-methylumbelliferyl-alpha-D-glucopyranoside). Establish a standard curve and include appropriate positive and negative controls in every assay.
• Protein–protein interaction studies: Pull-down assays, co-immunoprecipitation (co-IP), or surface plasmon resonance (SPR) to map interactions between GANAB and binding partners such as the PRKCSH (GII beta) subunit, calnexin, or calreticulin.
• Substrate specificity and inhibitor screening: In vitro profiling of potential glucosidase II inhibitors relevant to viral entry inhibition or therapeutic intervention in glycoprotein misfolding diseases.
• Antibody validation: Use as a positive control antigen in Western blot, ELISA, or immunofluorescence assays to validate anti-GANAB antibodies.
• Structural and biophysical studies: Circular dichroism (CD), dynamic light scattering (DLS), or cryo-EM sample preparation where a recombinant, well-defined protein source is required.

Key experimental considerations:

• Include a no-enzyme blank control to account for background substrate hydrolysis in activity assays.
• Confirm that assay buffer conditions (pH, ionic strength, metal ion requirements) are compatible with GANAB enzymatic activity; glucosidase II activity typically requires neutral to mildly acidic pH and may be influenced by divalent cation concentrations.
• Validate protein integrity by SDS-PAGE and/or activity assay upon receipt and after each freeze-thaw cycle.
• When using the protein for cell-based studies (e.g., exogenous addition), confirm cellular uptake or delivery strategy and assess potential immunogenicity.

Quality Control and Troubleshooting

Maintaining rigorous quality control (QC) practices protects data integrity and helps identify issues early. Below is a framework for QC and common troubleshooting scenarios.

Quality Control Checklist

• Review the Certificate of Analysis (CoA) upon receipt: confirm purity (SDS-PAGE/HPLC), endotoxin level, and activity data match the product specification.
• Visually inspect the vial for particulates or discoloration before use.
• Run an SDS-PAGE gel on a small aliquot to confirm molecular weight and purity at the expected band position.
• Perform a functional activity assay using a validated substrate to confirm active protein before committing to large-scale experiments.

Common Issues and Solutions